Tissue Diagnostics Market Size To Reach $18.58 Billion By 2033

May 2026 | Report Format: Electronic (PDF)

Tissue Diagnostics Market Growth & Trends

The global tissue diagnostics market size is expected to reach USD 18.58 billion by 2033, registering a CAGR of 9.11% from 2026 to 2033, according to a new report by Grand View Research, Inc. Accelerating demand for automated tissue diagnostic systems due to a lack of skilled pathologists has driven the tissue diagnostics industry. The advent of advanced imaging techniques, such as autofluorescence, that minimize the need for invasive diagnostics further supplements the market growth.

The use of digital slides has significantly increased in recent years, owing to its associated benefits including flexible magnification and remote access to slides. The growing emphasis on precision medicine is supported by several organizations & companies in the U.S., which is expected to contribute to the market growth. Additionally, companies are supporting the development of precision medicine with novel oncology solutions. For instance, in May 2020, QIAGEN launched new oncology solutions, such as the QCI Interpret One software solution for genomic profiling of tumors. The advancements in imaging techniques are expected to positively influence market growth.

In addition, one of the emerging trends in the tissue diagnostics industry is the integration of digital pathology and artificial intelligence (AI). Digital pathology involves the scanning and digitization of tissue slides, allowing pathologists to review and analyze images remotely. AI algorithms can then be applied to these digital images to aid in the interpretation and analysis of tissue samples. This integration enables faster and more accurate diagnoses, enhances workflow efficiency, and improves patient care. It also facilitates the development of predictive models and precision medicine approaches. As a result, there is a growing demand for digital pathology solutions and AI-driven tissue diagnostics platforms in the market.

With technological improvements in imaging techniques, the sensitivity of detection and diagnosis of breast cancer has also improved. For instance, in May 2023, with an emphasis on AI-guided breast cancer diagnoses, BPGbio recently announced an agreement with the Department of Defense (DoD). The new panel, created with artificial intelligence, is intended to detect women diagnosed with ER+ breast cancer but do not react to hormone therapy, allowing for more suitable treatment alternatives and improving treatment response.

The unique 34-gene breast cancer diagnostic panel from BPGbio will also receive wider evaluation through the Interrogative Biology Platform, focusing on ER+ breast cancers, which are significantly rising. Technological expansion in breast tissue analysis includes procedures for evaluating gene expression, cellular biochemistry, and molecular biology using digital methods, tomosynthesis, CAD, and other methods.

key Request a free sample copy or view report summary: Tissue Diagnostics Market Report

Tissue Diagnostics Market Report Highlights

The immunohistochemistry segment dominated the industry and accounting for the largest revenue share of 25.87% in 2025, driven by its extensive use in cancer diagnosis, biomarker analysis, and personalized treatment selection.
The breast cancer segment held the largest share of 50.72% in 2025, and is anticipated to grow at the fastest CAGR during the forecast period.
The hospitals segment dominated the market, accounting for the largest revenue share of 37.74% in 2025, driven by the increasing adoption of advanced cancer diagnostic technologies across hospital-based pathology laboratories.
The clinical segment dominated the market in 2025 and is expected to register the fastest CAGR of 9.53% over the forecast period.
North America tissue diagnostics market dominated the global industry, accounting for the largest revenue share of over 44% in 2025, driven by the increasing prevalence of cancer and growing demand for advanced diagnostic technologies across hospitals, pathology laboratories, and cancer research institutes.

Tissue Diagnostics Market Segmentation

Grand View Research has segmented the global tissue diagnostics market on the basis of technology, modality, application, end use, and region:

Tissue Diagnostics Technology Outlook (Revenue, USD Million, 2021 - 2033)

Immunohistochemistry
- Instruments
  - Slide Staining Systems
  - Tissue Microarrays
  - Tissue Processing Systems
  - Slide Scanners
  - Cell Processors
  - Microtomes
  - Embedding Systems
  - Cover Slippers
  - Other Products
- Consumables
  - H&E stainer coverslipper
  - IHC stainer coverslipper
  - Antibodies
  - Other IHC reagents
In Situ Hybridization
- Instruments
  - Stainers
  - Others
  - Total
- Consumables
- Software
Primary & Special Staining
Digital Pathology And Workflow
- Image Analysis Informatics
- Information Management System Storage & Communication
Anatomic Pathology
- Instruments
  - Microtomes & Cryostat Microtomes
  - Tissue Processors
  - Automatic Strainers
  - Other Products
- Consumables
  - Reagents & Antibodies
  - Probes & Kits
  - Others
Molecular Pathology
- Instruments
- Reagents
  - Fluorescence Reagents
  - Others
- Others